Examples of using Erbitux in English and their translations into Hungarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
back after previous treatment) or metastatic, Erbitux is used with a‘ platinum-based' anticancer medicine combination(including medicines such as cisplatin or carboplatin).
or metastatic, Erbitux is used with a‘platinum-based' anticancer medicine combination(including medicines such as cisplatin or carboplatin).
It is strongly recommended that Erbitux be given during pregnancy
Erbitux is indicated for the treatment of patients with epidermal growth factor receptor(EGFR)-expressing,
Erbitux is used in patients whose tumour cells have a protein on their surface called epidermal growth factor receptor(EGFR)
Erbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck• in combination with radiation therapy for locally advanced disease• in
Erbitux 2 mg/ ml is compatible• with polyethylene,
Erbitux 5 mg/ ml is compatible• with polyethylene(PE),
Erbitux 5 mg/mL is compatible with polyethylene(PE),
decided that Erbitux' s benefits are greater than its risks for the treatment of patients with EGFR-expressing, KRAS wild-type metastatic.
on 1 December 2003 for the medicinal product Erbitux, containing the active ingredient cetuximab.
to Merck KGaA for the medicinal product Erbitux, which is described as a‘solution for infusion(drip into a vein) that contains the active substance cetuximab'.
in patients who did not receive Erbitux.• the first study in patients who had taken chemotherapy before did not look at KRAS mutations.
For metastatic cancer of the colon or rectum, Erbitux was studied in five main studies:• two studies involved 1,535 patients who had not received chemotherapy before,
Other medicines and Erbitux.
How does Erbitux work?
Why has Erbitux been approved?
Erbitux contains cetuximab, a monoclonal antibody.
Erbitux 5 mg/mL is compatible.
What Erbitux contains• The active substance is cetuximab.